Gene expression profiling and TCR diversity of ATA188, a Pre-manufactured, Allogeneic Epstein-Barr Virus-targeted T-cell Immunotherapy for Patients with Multiple Sclerosis

Cytotherapy - Tập 22 - Trang S115 - 2020
P. Foubert1, S. Srihari2, L. Le Textier3, R.R. Shen1, F. Forozan1, C. Smith3, R. Khanna3, B.T. Aftab1
1Preclinical and Translational Science, Atara Biotherapeutics, Inc., Thousand Oaks, California, United States
2Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia
3Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

Thông tin
Thông tin xuất bản

Cytotherapy

Tập 22

S115

Thông tin tác giả